0.003
0.00 (50.00%)
| Previous Close | 0.002 |
| Open | 0.002 |
| Volume | 4,147,000 |
| Avg. Volume (3M) | 5,421,141 |
| Market Cap | 6,506,159 |
| Price / Earnings (Forward) | 0.160 |
| Price / Sales | 0.140 |
| Price / Book | 0.470 |
| 52 Weeks Range | |
| Earnings Date | 28 Feb 2025 |
| Profit Margin | -36.43% |
| Operating Margin (TTM) | -24.93% |
| Diluted EPS (TTM) | -0.010 |
| Quarterly Revenue Growth (YOY) | 3.90% |
| Total Debt/Equity (MRQ) | 56.44% |
| Current Ratio (MRQ) | 0.870 |
| Operating Cash Flow (TTM) | -1.98 M |
| Return on Assets (TTM) | -10.99% |
| Return on Equity (TTM) | -34.63% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Diagnostics & Research (SG) | Mixed | Mixed |
| Diagnostics & Research (Global) | Mixed | Mixed | |
| Stock | Clearbridge | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | -0.5 |
| Average | -1.25 |
Similar Stocks
| Stock | Market Cap | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| CLEARBRIDGE | 7 M | - | - | 0.470 |
| CORDLIFE | 51 M | - | - | 0.430 |
| HC SURGICAL | 45 M | 5.36% | 14.00 | 3.11 |
| EFH LTD | 42 M | - | - | 24.40 |
| ASIAMEDIC | 14 M | - | - | 1.11 |
|
Clearbridge Health Ltd provides health care services. It is an integrated healthcare group with end-to-end diagnostic abilities, deploying non-invasive tests to identify and manage illness. The segments are Strategic investments; Healthcare systems; Medical clinics; Corporate segment and Investment. It derives key revenue from the Healthcare systems and Medical clinics. The Healthcare systems segment involves, the provision of diagnostic services manufacturing of and research and development on diagnostic-related products, and provision of renal care services by partnering with medical device equipment manufacturers and hospitals. The Medical clinics segment involves, the provision of general medical and clinical services. The group has a business presence all over the world. |
|
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Investment Style | Small Value |
| % Held by Insiders | 43.39% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Chen (Johnson) | 10 Dec 2024 | 154,110,200 (8.29%) |
| Yee (Pinh Jeremy) | 10 Dec 2024 | 83,055,831 (4.47%) |
| Bonvests Holdings Ltd | 19 Mar 2024 | 41,330,500 (2.22%) |
| Amereus Group Pte. Ltd. | 19 Mar 2024 | 39,771,600 (2.14%) |
| Chen (Chung Ni Johnny) | 10 Dec 2024 | 31,059,800 (1.67%) |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 20 Jun 2025 | Announcement | General Announcement::USE OF PROCEEDS FROM THE RIGHTS ISSUE |
| 19 Jun 2025 | Announcement | Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)::Disclosure of Change in interest of Substantial Shareholders - Wong Kong Leong |
| 16 Jun 2025 | Announcement | Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)::Becoming a Substantial Shareholder - Wong Kong Leong |
| 16 Jun 2025 | Announcement | Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)::Cessation of Substantial Shareholder - Ong Choon Yi |
| 12 Jun 2025 | Announcement | Change - Change of Catalist Sponsor::Change of Continuing Sponsor |
| 06 Jun 2025 | Announcement | General Announcement::ENTRY INTO STRATEGIC ALLIANCE AGREEMENT |
| 29 May 2025 | Announcement | General Announcement::Minutes of the Annual General Meeting held on 30 April 2025 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |